Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DRD1 | P21728 | 9/20 | 0.62 |
| ▸ | DRD2 | P14416 | 8/20 | 0.62 |
| ▸ | DRD3 | P35462 | 8/20 | 0.62 |
| ▸ | DRD5 | P21918 | 8/20 | 0.62 |
| ▸ | DRD4 | P21917 | 5/20 | 0.62 |
| ▸ | STS | P08842 | 1/20 | 0.55 |
| ▸ | CHRNA7 | P36544 | 1/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.53 |
| ▸ | BCL2 | P10415 | 1/20 | 0.52 |
| ▸ | NPC1 | O15118 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | RAB9A | P51151 | 1/20 | 0.51 |
| ▸ | KDM1A | O60341 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30299229 | 1.00 | DRD1 (0.62) | DRD1DRD2DRD3DRD5DRD4 | |
| SCHEMBL30888625 | 0.98 | DRD1 (0.60) | DRD1DRD2DRD3DRD5DRD4 | |
| SCHEMBL4133301 | 0.98 | DRD1 (0.60) | DRD1DRD2DRD3DRD5DRD4 | |
| SCHEMBL20231604 | 0.98 | DRD1 (0.60) | DRD1DRD2DRD3DRD5DRD4 | |
| SCHEMBL31028084 | 0.95 | DRD1 (0.62) | DRD1DRD2DRD3DRD5DRD4 | |
| SCHEMBL1506557 | 0.95 | DRD1 (0.62) | DRD1DRD2DRD3DRD5DRD4 | |
| Methylene Chloride SCHEMBL29094368 | 0.92 | DRD1 (0.55) | DRD1DRD2DRD3DRD5DRD4 | |
| SCHEMBL2607471 | 0.91 | DRD1 (0.62) | DRD1DRD2DRD3DRD5DRD4 | |
| Propylamine SCHEMBL9435187 | 0.87 | DRD2 (0.51) | DRD1DRD2DRD3DRD5DRD4 | |
| Acrylonitrile SCHEMBL14856533 | 0.84 | DRD1 (0.49) | DRD1DRD2DRD3DRD5DRD4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 249 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116730810-A | Synthesis method of medical intermediate 6-methoxy-1-tetralone | 上海常丰生物医药科技有限公司 | 2023-09-12 | — | — | CN | claimed |
| CN-114249352-A | Method for treating wastewater generated in production of 6-methoxy tetralone | 沈阳化工研究院有限公司 | 2022-03-29 | — | — | CN | claimed |
| US-20080182333-A1 | Fluorescent chemosensors for metals based on dipyrrins | STC.UNM | 2008-07-31 | — | — | US | claimed |
| EP-0204975-B1 | PROCESS FOR PREPARING SUBSTITUTED TETRALONES | ETHYL CORPORATION (US) | 1991-07-17 | — | — | EP | claimed |
| EP-0204975-A2 | Process for preparing substituted tetralones | ETHYL CORPORATION (US) | 1986-12-17 | — | — | EP | claimed |
| US-4603221-A | 6-ALKOXYTETRALIN, TRANSITION METAL SALT, TERTIARY AMINE, AMMONIUM OR ALKALI METAL PERSULFATE, OXIDATION | ETHYL CORPORATION (US) | 1986-07-29 | — | — | US | claimed |
| JP-61003892-A | — | — | None | — | — | JP | disclosed |
| CN-121824281-A | Method for preparing 6-methoxy-1-tetralone by photocatalytic oxidation | 江苏信和生物医药有限公司 | 2026-04-10 | — | — | CN | disclosed |
| EP-4706820-A1 | ENANTIOSELECTIVE C-H AMINATION WITH IRON PHTHALOCYANINE AND DIAMMONIUM TEMPLATE CATALYSTS | The University Of Hong Kong (CN) | 2026-03-11 | — | — | EP | disclosed |
| US-20260062406-A1 | Benzisoxazole Sulfonamide Derivatives | PFIZER (US) | 2026-03-05 | — | — | US | disclosed |
| US-20260062393-A1 | Compounds | CTXT PTY LTD (AU) | 2026-03-05 | — | — | US | disclosed |
| EP-4692094-A1 | SULFONAMIDE COMPOUND, PHARMACEUTICAL COMPOSITION THEREOF AND USE THEREOF | Beijing Konruns Pharmaceutical Co., Ltd. (CN) | 2026-02-11 | — | — | EP | disclosed |
| EP-4680226-A2 | ACYLSULFONAMIDE KAT6A INHIBITORS | Olema Pharmaceuticals, Inc. (US) | 2026-01-21 | — | — | EP | disclosed |
| EP-0088346-B1 | 2-AMINOMETHYL-PHENOL DERIVATIVES, PROCESS FOR THEIR PREPARATION, THEIR USE AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEM | HOECHST AKTIENGESELLSCHAFT (DE) | 1985-06-05 | — | — | EP | disclosed |
| WO-1984004247-A1 | BICYCLIC BENZENOID AMINOALKYLENE ETHERS AND THIOETHERS, AND THEIR PHARMACEUTICAL USES | RORER INT OVERSEAS (US) | 1984-11-08 | — | — | WO | disclosed |
| EP-0088345-A2 | 2-Aminomethyl-6-sulfamoylphenol derivatives, process for their preparation, their use and pharmaceutical preparations based on these compounds | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-09-14 | — | — | EP | disclosed |
| EP-0088346-A2 | 2-Aminomethyl-phenol derivatives, process for their preparation, their use and pharmaceutical compositions containing them | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-09-14 | — | — | EP | disclosed |
| US-4294992-A | Process for the production of alkyl aryl ethers | THE SOUTHLAND CORPORATION (US) | 1981-10-13 | — | — | US | disclosed |
| US-4048330-A | Compositions containing 2-(6'-substituted-2'-naphthyl)acetic acid esters used for treating inflammation, pain or pyrexia | SYNTEX CORPORATION (US) | 1977-09-13 | — | — | US | disclosed |
| US-4009197-A | 2-(6-Substituted-2'-naphthyl) acetic acid derivatives and the salts and esters thereof | SYNTEX CORPORATION (PM) | 1977-02-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260062393-A1 | Compounds | SCN2B, ABCB11, SCN1B | DRD1 74/4885DRD2 44/4885DRD3 100/4885 |
| US-20260062406-A1 | Benzisoxazole Sulfonamide Derivatives | KAT8, KAT5, KAT7 | DRD1 4521/4885DRD2 4760/4885DRD3 4607/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.